ELISA screening for Lyme disease in children with chronic arthritis.

One hundred patients, aged 6-15 years and presented to El-Shatby University Children's Hospital with chronic/recurrent arthritis and skin lesions suggestive of erythema chronicum migrans (ECM), were investigated for presence of IgG antibodies against Borrelia burgdorferi flagellum antigen ELISA test. Four cases yielded positive serum samples which were true positive cases as they showed negative Venereal Disease Research Laboratory (VDRL) test. Ticks collected from domestic animals from the houses of serologically positive patients were found belonging to hard tick: Rhipicephalus sanguineus. Based on clinical ground, only one case was strongly suspected to have Lyme disease due to the presence of the distinctive skin lesion (ECM) while the other three cases were not diagnosed till the results of serological test. This study provides serological evidence concerning the presence of Lyme disease in Egypt. Further efforts of identify its prevalence, various clinical presentations, vectors and animal hosts are warranted.
AuthorsN A Hammouda, I H Hegazy, E H el-Sawy
JournalJournal of the Egyptian Society of Parasitology (J Egypt Soc Parasitol) Vol. 25 Issue 2 Pg. 525-33 (Aug 1995) ISSN: 1110-0583 [Print] EGYPT
PMID7665949 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulin G
  • Adolescent
  • Animals
  • Animals, Domestic
  • Antibodies, Bacterial (blood)
  • Arthritis (diagnosis)
  • Borrelia burgdorferi Group
  • Child
  • Enzyme-Linked Immunosorbent Assay (methods)
  • Female
  • Horses
  • Humans
  • Immunoglobulin G (blood)
  • Lyme Disease (diagnosis, prevention & control)
  • Male
  • Mass Screening
  • Ticks (classification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: